4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-21-064924
COO & Chief Financial Officer acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
LOWE CHRISTOPHER P. · COO & Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-11-16 | Exercise or conversion : show line 1 in the form | +30,000 | $2.23 | $66,900 | 90,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-11-16 | Exercise or conversion : show line 2 in the form Stock Option (right to buy) | −30,000 | 103,294 | D |
Loading xslF345X03/doc4.xml…